OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/12/2025
Voltar para busca
Dado oficial do USPTO
DRUG DISCOVERY AI FACTORY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DRUG DISCOVERY AI FACTORY
ST13
US500000079393432Classe
9, 35, 41, 42
Pedido
79393432
Registro
7665758
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 41, 42
Data de depósito
13/12/2023
Data de registro
28/01/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/01/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
JP
Examinador
PARKS, KIMBERLY L
Unidade examinadora
M30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
FRONTEO, Inc.
Representantes
Tomoko Nakajima Future IP LLC
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; downloadable computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; downloadable computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; downloadable computer programs for proposing and searching indications; downloadable computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; devices for analyzing electronic images; downloadable computer programs for data processing; devices for data processing; computer hardware for data processing
Classe 35
Compilation of information into computer databases for research in the field of pharmaceuticals
Classe 41
Providing information on educational and instruction services relating to medicine and pharmaceuticals; arranging and conducting seminars relating to medicine and pharmaceuticals; instruction services in the field of pharmaceuticals
Classe 42
Providing on-line non-downloadable computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for proposing and searching indications; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; provision of information search engines via internet; designing and creating services of home pages and websites; designingprogrammingmaintenance of computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; designingprogrammingmaintenance of computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; designingprogrammingmaintenance of computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; designingprogrammingmaintenance of computer programs for proposing and searching indications; designingprogrammingmaintenance of computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; scientific testinginspection and research for making a hypothesis on relationships between genes and diseases; testinginspection or research of pharmaceuticals; consulting services relating to testinginspection and research of pharmaceuticals; providing information on research of pharmaceuticals; drug discovery services; research and scientific inspection of pharmaceuticals relating to genetic analysis; scientific testing and research on health equipment; rental of measuring and testing instruments; rental of measuring apparatus; hosting web portals on the Internet; rental of server memory space for social networking websites; rental of computers
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/11/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
26/11/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/08/2025
FIMP
FINAL DISPOSITION PROCESSED
15/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
28/01/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2024
PUBO
PUBLISHED FOR OPPOSITION
10/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2024
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
18/09/2024
RFNT
REFUSAL PROCESSED BY IB
25/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/08/2024
RFRR
REFUSAL PROCESSED BY MPU
07/08/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/07/2024
CNRT
NON-FINAL ACTION WRITTEN
20/07/2024
DOCK
ASSIGNED TO EXAMINER
11/07/2024
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
30/06/2024
MAFR
APPLICATION FILING RECEIPT MAILED
23/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/04/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
16/04/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/04/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DRUG DISCOVERY AI FACTORY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.